Back to News
Market Impact: 0.6

Earnings call transcript: Oxford Industries Q1 2025 misses EPS forecast, stock drops

OXM
Corporate EarningsCorporate Guidance & OutlookTax & TariffsTrade Policy & Supply ChainConsumer Demand & RetailCompany FundamentalsAnalyst InsightsTravel & Leisure
Earnings call transcript: Oxford Industries Q1 2025 misses EPS forecast, stock drops

Oxford Industries (OXM) reported Q1 fiscal 2025 EPS of $1.82, missing the $1.98 forecast, while revenue exceeded expectations at $393 million versus $383.54 million. The stock subsequently dropped 8.6%, closing at $54.74, reflecting investor disappointment with the EPS miss. For the full year, OXM projects net sales between $1.475 billion and $1.515 billion and adjusted EPS of $2.80 to $3.20, a significant decrease from last year's $6.68, citing a challenging consumer environment, increased tariff costs which are expected to contract gross margins by 200 basis points, and efforts to diversify its supply chain away from China.

Analysis

Oxford Industries (OXM) reported a mixed first-quarter fiscal 2025, with earnings per share (EPS) of $1.82 falling short of the $1.98 forecast, triggering an 8.6% decline in its stock price during regular trading. Conversely, revenue surpassed expectations at $393 million against a $383.54 million forecast, although this represented a slight year-over-year decrease from $398 million. The company's adjusted operating profit was $39 million, yielding a 9.8% operating margin, reflecting a challenging consumer environment characterized by cautious discretionary spending. Despite these immediate pressures, InvestingPro data indicates impressive gross profit margins of 62.9% and a P/E ratio of 8.5, suggesting potential undervaluation. However, the full-year outlook is significantly dampened, with projected net sales between $1.475 billion and $1.515 billion and an adjusted EPS guidance of $2.80 to $3.20, a steep decline from $6.68 in the previous year. This revision is largely attributed to an anticipated $40 million in additional tariff costs, expected to contract gross margins by 200 basis points, and ongoing efforts to diversify the supply chain away from China, with plans to be substantially out by the second half of 2026. Management acknowledged operating in "very difficult circumstances" but highlighted resilience, innovation, and progress in tariff mitigation, aiming for full mitigation by Spring 2026. The Lilly Pulitzer brand demonstrated strength with double-digit growth by focusing on core customers, while challenges persist in improving profitability for the Johnny Was brand. Inventory levels rose 12% (LIFO basis) due to accelerated purchases ahead of tariff implementations and increased capitalized costs. The company maintains a 55-year streak of dividend payments, currently yielding 5.04%.